[PDF] Top 20 Intravitreal Bevacizumab with Grid Photocoagulation for Recurrent Macular Edema Secondary to Retinal Vein Occlusion

... Intravitreal injections were performed under complete sterile conditions using bovidine iodine 10% for eye lid skin and 5% for ocular surface wash. After complete draping, surface anesthesia was applied. ... See full document

... their macular edema recurred, and those who received continuous monthly IVB throughout the study ...with recurrent macular edema, so that it is difficult to compare our current results ... See full document

... that macular edema secondary to BRVO causes decreased visual acuity, many efforts have been made to reduce macular edema to achieve improve- ment in visual acuity after ...of ... See full document

... mellitus, a history of intravitreal triamcinolone injection(s) or grid laser photocoagulation therapy, or ischemic BRVO were excluded from this study. All eyes had a complete ophthal- mologic ... See full document

... of intravitreal injections of bevacizumab (IVB) as needed over 6 months in patients with macular edema secondary to CRVO, and we performed multivariate analysis to determine the factors ... See full document

... monthly intravitreal treatment with an anti-VEGF agent, ranibizumab, on both macular edema and visual acuity in patients with retinal vein ...with Macular Edema ... See full document

... Best-corrected visual acuity (BCVA) was measured with the Snellen chart, CMT was measured with OCT at the innermost 1 mm diameter circle and IOP was measured with a noncon- tact tonometer at the time of first injection, ... See full document

... developed recurrent ME during a 1-year period, with slightly higher recurrence before 6 ...of grid laser to recurrent cases with plenty of exudates may decrease recurrence after 6 months, but it ... See full document

... Branch retinal vein occlusion (BRVO) is the next most common retinal vascular disorder following diabetic retinopathy, and macular edema is the most frequent cause of visual ... See full document

... of intravitreal ranibizumab (IVR) for treating macular edema in pa- tients with RVO ...treating macular edema secondary to RVO has been ...ranibizumab, bevacizumab, and ... See full document

... of retinal ischemia in the occluded region ...of retinal ischemia in the occluded region alone. Generally, retinal ischemia is associated with capillary ...fused retinal area in BRVO patients ... See full document

... including photocoagulation therapy, sub-Tenon’s injection of triamcinolone acetonide or intravitreal injection of steroids, tissue plasminogen activator, or anti-VEGF drugs; central retinal thickness ... See full document

... hemorrhage, retinal ischemia and persistent macular edema and neovascular glaucoma secondary to iris neo- ...and retinal ischemia develop in 34% of patients with ...the secondary ... See full document

... (Heidelberg Retinal Angiogram-2; Heidelberg Engineering GmBH, Dossenheim, Germany) and optical coherence tomography (OCT) (Stratus III OCT™; Carl Zeiss Meditec AG, Jena, Germany) at presentation to the ... See full document

... compared bevacizumab alone or combined with macular laser photocoagulation for the treatment of macular edema secondary to ...of bevacizumab and ranibizumab treatments of ... See full document

... or recurrent macular edema (central macula thickness ...received intravitreal injections of ziv-aflibercept ...intraretinal edema or subretinal fluid seen on spectral domain optical ... See full document

... mean macular thickness within the 10 degree and 20 degree fields showed a decrease at 3 and 6 months after IVTA (Figure ...mean macular sensitivity within the central 4, 10, and 20 degree fields was ... See full document

... other retinal vascular diseases (diabetic retinopathy, age related degeneration), glaucoma, previous treatments for CRVO (intravitreals or laser-photocoagulation), iris neovascu- larization and > 10 disc ... See full document

... Macular Edema (FAME) studies were two large prospec- tive, randomized, controlled studies that followed 956 eyes randomized to receive ...group. Retinal thickness was significantly reduced in both ... See full document

... Diabetic macular edema (DME) has shown an increasing prevalence during the past years and is the leading cause of diabetic retinopathy ...the intravitreal injection of anti-VEGF drugs has become the ... See full document